Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,819
archived clinical trials in
Brain Cancer

Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated:  4/27/2017
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated: 4/27/2017
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated:  4/27/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated: 4/27/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated:  4/27/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Cediranib, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
A Phase Ib/II Study of AZD2171 in Combination With Daily Temozolomide and Radiation in Patients With Newly Diagnosed Glioblastoma Not Taking Enzyme-Inducing Anti-epileptic Drugs
Status: Enrolling
Updated: 4/27/2017
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Status: Enrolling
Updated:  4/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Status: Enrolling
Updated: 4/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma.
Status: Enrolling
Updated:  5/8/2017
University of Louisville, Kosair Charities Pediatric Clinical Research Unit
mi
from
Louisville, KY
Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and Sarcoma
A Phase I Trial Combining Decitabine and Vaccine Therapy for Patients With Relapsed Neuroblastoma and Sarcoma.
Status: Enrolling
Updated: 5/8/2017
University of Louisville, Kosair Charities Pediatric Clinical Research Unit
mi
from
Louisville, KY
Click here to add this to my saved trials
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
Genetic Variation and Risk of Pediatric Brain Cancers
Status: Enrolling
Updated:  5/8/2017
Washington University
mi
from
Saint Louis, MO
Neurofibromatosis Type 1 Brain Tumor Genetic Risk
Genetic Variation and Risk of Pediatric Brain Cancers
Status: Enrolling
Updated: 5/8/2017
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
A Phase II Study o the Adjuvant Use of Anti-Epidermal Growth Factor Receptor-425 (Anti-EGFR-425) Monoclonal Antibody Radiolabeled With I-125 for High Grade Gliomas
Status: Enrolling
Updated:  5/8/2017
Hahneman Hospital
mi
from
Philadelphia, PA
A Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
A Phase II Study o the Adjuvant Use of Anti-Epidermal Growth Factor Receptor-425 (Anti-EGFR-425) Monoclonal Antibody Radiolabeled With I-125 for High Grade Gliomas
Status: Enrolling
Updated: 5/8/2017
Hahneman Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated:  5/17/2017
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
A Phase I Study Of Irinotecan and Bevacizumab With Temozolomide in Children With Recurrent/Refractory Central Nervous System Tumors
Status: Enrolling
Updated: 5/17/2017
Johns Hopkins All Children's Hospital
mi
from
Saint Petersburg, FL
Click here to add this to my saved trials
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Safety of Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma: A Pilot Study
Status: Enrolling
Updated:  5/22/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Safety of Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma: A Pilot Study
Status: Enrolling
Updated: 5/22/2017
Memorial Sloan-Kettering Cancer Center @ Suffolk
mi
from
Commack, NY
Click here to add this to my saved trials
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Safety of Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma: A Pilot Study
Status: Enrolling
Updated:  5/22/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma
Safety of Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma: A Pilot Study
Status: Enrolling
Updated: 5/22/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated:  6/19/2017
Warrior Recovery Center
mi
from
Colorado Springs, CO
"Interactive Metronome Technology for Blast-Related Traumatic Brain Injury"
"A Randomized, Controlled, Trial of Interactive Metronome Technology for Remediation of Cognitive Difficulties Following Blast-Related Traumatic Brain Injury"
Status: Enrolling
Updated: 6/19/2017
Warrior Recovery Center
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)
Status: Enrolling
Updated:  6/26/2017
University of Chicago
mi
from
North Chicago, IL
Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Biologic Endpoints in the Annihilation of Metastases for Oligometastasis (BEAM ON)
Status: Enrolling
Updated: 6/26/2017
University of Chicago
mi
from
North Chicago, IL
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
University of Alabama-Birmingham /ID# 131879
mi
from
Birmingham, AL
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
University of Alabama-Birmingham /ID# 131879
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
UCLA /Id# 137975
mi
from
Los Angeles, CA
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
UCLA /Id# 137975
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
University of California, San Francisco /ID# 129969
mi
from
San Francisco, CA
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
University of California, San Francisco /ID# 129969
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Northwestern University /ID# 106817
mi
from
Chicago, IL
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Northwestern University /ID# 106817
mi
from
Chicago, IL
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
NorthShore University HealthSystem /ID# 106816
mi
from
Evanston, IL
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
NorthShore University HealthSystem /ID# 106816
mi
from
Evanston, IL
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Dana Farber Cancer Institute /ID# 95737
mi
from
Boston, MA
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Dana Farber Cancer Institute /ID# 95737
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Massachusetts General Hospital /ID# 127615
mi
from
Boston, MA
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Massachusetts General Hospital /ID# 127615
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Henry Ford Hospital /ID# 133570
mi
from
Detroit, MI
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Henry Ford Hospital /ID# 133570
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Columbia University Medical Center /ID# 92313
mi
from
New York, NY
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Columbia University Medical Center /ID# 92313
mi
from
New York, NY
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
The University of Texas - MD Anderson Cancer Center /ID# 94339
mi
from
Houston, TX
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
The University of Texas - MD Anderson Cancer Center /ID# 94339
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
South Texas Accelerated Research Therapeutics, LLC /ID# 91153
mi
from
San Antonio, TX
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
South Texas Accelerated Research Therapeutics, LLC /ID# 91153
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
University of Utah /ID# 131769
mi
from
Salt Lake City, UT
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
University of Utah /ID# 131769
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated:  7/6/2017
Royal Brisbane and Womens Hospital /ID# 133368
mi
from
Brisbane,
Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma Multiforme
Status: Enrolling
Updated: 7/6/2017
Royal Brisbane and Womens Hospital /ID# 133368
mi
from
Brisbane,
Click here to add this to my saved trials
Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
A Dose-Escalating Phase I Study for Safety and Tolerability of Bevacizumab in Collagen Delivery Vehicle Administered Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
Status: Enrolling
Updated:  7/11/2017
Brain and Spine Surgeons of New York
mi
from
White Plains, NY
Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
A Dose-Escalating Phase I Study for Safety and Tolerability of Bevacizumab in Collagen Delivery Vehicle Administered Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence
Status: Enrolling
Updated: 7/11/2017
Brain and Spine Surgeons of New York
mi
from
White Plains, NY
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Arizona Oncology Services Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
UCSF University of California San Francisco Medical Center-Mount Zion
mi
from
San Francisco, CA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
UCSF University of California San Francisco Medical Center-Mount Zion
mi
from
San Francisco, CA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
University of Florida
mi
from
Gainesville, FL
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Mayo Clinic Florida
mi
from
Jacksonville, FL
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Florida Hospital
mi
from
Orlando, FL
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Emory University
mi
from
Atlanta, GA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Memorial Health University Medical Center
mi
from
Savannah, GA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Memorial Health University Medical Center
mi
from
Savannah, GA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Northwestern University
mi
from
Chicago, IL
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Loyola University Medical Center
mi
from
Maywood, IL
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Oncology Associates PC
mi
from
Fort Wayne, IN
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Oncology Associates PC
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Parkview Hospital
mi
from
Fort Wayne, IN
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Parkview Hospital
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Saint Vincent Oncology Center
mi
from
Indianapolis, IN
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Saint Vincent Oncology Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
McFarland Clinic, PC
mi
from
Ames, IA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
McFarland Clinic, PC
mi
from
Ames, IA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
June E. Nylen Cancer Center
mi
from
Sioux City, IA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
June E. Nylen Cancer Center
mi
from
Sioux City, IA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Via Christi Regional Medical Center
mi
from
Wichita, KA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Via Christi Regional Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Wesley Medical Center
mi
from
Wichita, KA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Wesley Medical Center
mi
from
Wichita, KA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Maine Medical Center
mi
from
Scarborough, ME
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Maine Medical Center
mi
from
Scarborough, ME
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Boston Med Ctr
mi
from
Boston, MA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Massachussets General Hospital Cancer Center
mi
from
Boston, MA
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Massachussets General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Saint Joseph Mercy Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
Henry Ford Hospital
mi
from
Detroit, MI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated:  7/26/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Phase III Trial of Anaplastic Glioma Without 1p/19q LOH
Phase III Trial on Concurrent and Adjuvant Temozolomide Chemotherapy in Non-1p/19q Deleted Anaplastic Glioma. The CATNON Intergroup Trial.
Status: Enrolling
Updated: 7/26/2017
West Michigan Cancer Center
mi
from
Kalamazoo, MI
Click here to add this to my saved trials